Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

R. Marks · SciRah

Researcher profile · Semantic Scholar

R. Marks

Share profile

R. Marks — researcher profile on SciRah

h-index: 49
Works: 149
Citations: 7,830

Most-cited papers

Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003.
Ping Yang, M. Allen, M. Aubry, J. Wampfler +6 more
2005Chest394 citations
Semantic Scholar
Genetic variants and risk of lung cancer in never smokers: a genome-wide association study
Ya-Fei Li, C. Sheu, Yuan-Qing Ye, M. de Andrade +25 more
2010The Lancet Oncology229 citations Open access
Semantic Scholar
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study.
C. Chee, A. Ashrani, R. Marks, T. Petterson +3 more
2014Blood203 citations Open access
Semantic Scholar
The detection and treatment of cancer-related functional problems in an outpatient setting
A. Cheville, Lisa A. Beck, T. L. Petersen, R. Marks +1 more
2008Supportive Care in Cancer171 citations
Semantic Scholar
Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.
H. Niell, J. Herndon, Antonius A. Miller, D. Watson +9 more
2005Journal of Clinical Oncology156 citations
Semantic Scholar
Original Articles: EpidemiologyQuality of Life and Symptom Burden among Long-Term Lung Cancer Survivors
Ping Yang, A. Cheville, J. Wampfler, Yolanda I. Garces +15 more
2012149 citations Open access
Semantic Scholar
Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases.
Zhi-Fu Sun, M. Aubry, C. Deschamps, R. Marks +5 more
2006Journal of Thoracic and Cardiovascular Surgery147 citations Open access
Semantic Scholar
Worse disease-free survival in never-smokers with ALK+ lung adenocarcinoma
Ping Yang, K. Kulig, J. Boland, M. Erickson-Johnson +12 more
2012Journal of Thoracic Oncology142 citations Open access
Semantic Scholar
Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk.
Ping Yang, Zhi-Fu Sun, M. Krowka, M. Aubry +8 more
2008Archives of Internal Medicine142 citations Open access
Semantic Scholar
Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers
D. Xie, R. Marks, Mingrui Zhang, G. Jiang +5 more
2015Journal of Thoracic Oncology134 citations Open access
Semantic Scholar
Prognostic factors differ by tumor stage for Small Cell Lung Cancer: A Pooled Analysis of North Central Cancer Treatment Group (NCCTG) Trials
N. Foster, S. Mandrekar, S. E. Schild, G. Nelson +6 more
2009Cancer133 citations Open access
Semantic Scholar
A prognostic model for advanced stage nonsmall cell lung cancer
S. Mandrekar, S. Schild, S. Hillman, K. L. Allen +8 more
2006Cancer119 citations
Semantic Scholar
Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597.
D. Karp, Sandra J. Lee, S. Keller, G. Wright +13 more
2013Journal of Clinical Oncology102 citations Open access
Semantic Scholar
Phase I Trial of Sorafenib in Combination with Gefitinib in Patients with Refractory or Recurrent Non–Small Cell Lung Cancer
A. Adjei, J. Molina, S. Mandrekar, R. Marks +7 more
2007Clinical Cancer Research97 citations Open access
Semantic Scholar
Effect of Emphysema on Lung Cancer Risk in Smokers: A Computed Tomography-based Assessment
Yan Li, S. Swensen, L. Karabekmez, R. Marks +8 more
2010Cancer Prevention Research96 citations Open access
Semantic Scholar
Prognostic factors for limited-stage small cell lung cancer: A study of 284 patients
Jun Chen, Ruoxiang Jiang, Y. Garces, A. Jatoi +5 more
2009Lung Cancer92 citations Open access
Semantic Scholar
Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
J. Buckner, K. Ballman, J. Michalak, G. Burton +7 more
2006Journal of Clinical Oncology86 citations Open access
Semantic Scholar
Risk Factors for Incident Venous Thromboembolism in Active Cancer Patients: A Population Based Case-Control Study
A. Ashrani, R. Gullerud, T. Petterson, R. Marks +2 more
2016Thrombosis Research74 citations Open access
Semantic Scholar
Risk of Site-Specific Cancer in Incident Venous Thromboembolism: A Population-Based Study
T. Petterson, R. Marks, A. Ashrani, K. Bailey +1 more
2014Thrombosis Research74 citations Open access
Semantic Scholar
Modified Masaoka Stage and Size Are Independent Prognostic Predictors in Thymoma and Modified Masaoka Stage Is Superior to Histopathologic Classifications
A. Roden, E. Yi, Sarah M. Jenkins, Kelly K. Edwards +5 more
2015Journal of Thoracic Oncology72 citations Open access
Semantic Scholar
Chromoplectic TPM3–ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib
Aaron S. Mansfield, S. Murphy, F. Harris, Steven I. Robinson +8 more
2016Annals of Oncology71 citations Open access
Semantic Scholar
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial
E. Galanis, Katharine E Dooley, S. Anderson, C. Kurokawa +18 more
2024Nature Communications70 citations Open access
Semantic Scholar
α1-Antitrypsin and Neutrophil Elastase Imbalance and Lung Cancer Risk
Ping Yang, W. Bamlet, Zhi-Fu Sun, J. Ebbert +9 more
200570 citations
Semantic Scholar
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
Elizabeth A. Johnson, R. Marks, S. Mandrekar, S. Hillman +13 more
2008Lung Cancer69 citations
Semantic Scholar
Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590.
H. Wakelee, P. Stephenson, S. Keller, H. Wagner +6 more
2005Lung Cancer68 citations
Semantic Scholar
Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA
Liang Wang, J. Aakre, Ruoxiang Jiang, R. Marks +5 more
2010Journal of Thoracic Oncology67 citations Open access
Semantic Scholar
Genome-wide association study of genetic predictors of overall survival for non-small cell lung cancer in never smokers
Xi-Feng Wu, Liang Wang, Yuan-Qing Ye, J. Aakre +20 more
2013Cancer Research64 citations Open access
Semantic Scholar
Wnt Signaling Pathway Pharmacogenetics in Non-Small Cell Lung Cancer
D. Stewart, D. Chang, Yuan-Qing Ye, M. Spitz +7 more
2014The Pharmacogenomics Journal58 citations Open access
Semantic Scholar
Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
S. Schild, J. Bonner, S. Hillman, T. Kozelsky +8 more
2007Journal of Clinical Oncology58 citations
Semantic Scholar
Chemotherapy for Advanced CNS Ependymoma
M. Gornet, J. Buckner, R. Marks, B. Scheithauer +1 more
2004Journal of Neuro-Oncology56 citations
Semantic Scholar
Phase I Trial of Sirolimus Combined with Radiation and Cisplatin in Non-small Cell Lung Cancer
J. Sarkaria, P. Schwingler, S. Schild, P. Grogan +9 more
2007Journal of Thoracic Oncology48 citations Open access
Semantic Scholar
The association of active cancer with venous thromboembolism location: a population-based study.
A. Tafur, H. Kalsi, W. Wysokinski, R. McBane +6 more
2011Mayo Clinic proceedings45 citations Open access
Semantic Scholar
Reproducibility of 3 Histologic Classifications and 3 Staging Systems for Thymic Epithelial Neoplasms and Its Effect on Prognosis
A. Roden, E. Yi, Sarah M. Jenkins, Kelly K. Edwards +6 more
2015American Journal of Surgical Pathology44 citations
Semantic Scholar
NUT midline carcinoma: an aggressive intrathoracic neoplasm.
S. Parikh, C. French, B. Costello, R. Marks +7 more
2013Journal of Thoracic Oncology44 citations Open access
Semantic Scholar
A phase II trial of the Src-kinase inhibitor saracatinib after 4 cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621
J. Molina, N. Foster, T. Reungwetwattana, G. Nelson +6 more
2014Lung Cancer42 citations Open access
Semantic Scholar
Histopathologic and Cytogenetic Features of Pulmonary Adenoid Cystic Carcinoma
A. Roden, P. Greipp, D. Knutson, S. Kloft‐Nelson +4 more
2015Journal of Thoracic Oncology41 citations Open access
Semantic Scholar
Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort.
A. Jatoi, B. Williams, Frank Nichols, R. Marks +4 more
2005Lung Cancer41 citations
Semantic Scholar
Brief Report: A Phase II “Window-of-Opportunity” Frontline Study of the mTOR Inhibitor, Temsirolimus Given as a Single Agent in Patients with Advanced NSCLC, an NCCTG Study
T. Reungwetwattana, J. Molina, S. Mandrekar, Katie Allen-Ziegler +8 more
2012Journal of Thoracic Oncology40 citations Open access
Semantic Scholar
A phase I study of BAY 43-9006 and gefitinib in patients with refractory or recurrent non-small-cell lung cancer (NSCLC)
A. Adjei, S. Mandrekar, R. Marks, L. Hanson +5 more
200540 citations
Semantic Scholar
Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients.
Z. Sun, J. Chen, J. Aakre, R. Marks +7 more
2010Annals of Oncology38 citations Open access
Semantic Scholar
Management of multifocal lung cancer: Results of a survey
K. Leventakos, T. Peikert, D. Midthun, J. Molina +20 more
2017Journal of Thoracic Oncology37 citations Open access
Semantic Scholar
Endpoints in Phase II trials for advanced non-small cell lung cancer
S. Mandrekar, Y. Qi, S. Hillman, K. L. Allen Ziegler +6 more
2010Journal of Thoracic Oncology37 citations Open access
Semantic Scholar
Alpha1-antitrypsin and neutrophil elastase imbalance and lung cancer risk.
Ping Yang, W. Bamlet, Zhi-Fu Sun, J. Ebbert +10 more
2005Chest37 citations
Semantic Scholar
Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers†
D. Xie, M. Allen, R. Marks, G. Jiang +12 more
2018European Journal of Cardio-Thoracic Surgery32 citations Open access
Semantic Scholar
Small-cell Lung Cancer in Very Elderly (≥ 80 Years) Patients.
S. Schild, Liming Zhao, J. Wampfler, T. Daniels +8 more
2019Clinical Lung Cancer28 citations
Semantic Scholar
Extraskeletal Osteosarcoma: Outcomes and the Role of Chemotherapy
J. Paludo, K. Fritchie, C. Haddox, P. Rose +5 more
2017American Journal of Clinical Oncology28 citations Open access
Semantic Scholar
Phase 1 Study of Sorafenib in Combination with Bortezomib in Patients with Advanced Malignancies
Shaji K. Kumar, J. Jett, R. Marks, R. L. Richardson +11 more
2013Investigational new drugs26 citations Open access
Semantic Scholar
Genetic Variants Associated with the Risk of Chronic Obstructive Pulmonary Disease with and without Lung Cancer
M. de Andrade, Yan Li, R. Marks, C. Deschamps +10 more
2011Cancer Prevention Research26 citations Open access
Semantic Scholar
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
A. Desai, S. Rakshit, R. Bansal, Y. Ashara +16 more
2023Cancer Treatment and Research Communications25 citations Open access
Semantic Scholar
Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report
F. Mateen, A. Jatoi, T. Lineberry, D. Aranguren +6 more
2008Psycho-Oncology25 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Ping Yang×18
Invite
Ping Yang — researcher profile on SciRah
M. Aubry×13
Invite
M. Aubry — researcher profile on SciRah
J. Molina×11
Invite
J. Molina — researcher profile on SciRah
A. Adjei×10
Invite
A. Adjei — researcher profile on SciRah

×10

Invite

C. Deschamps — researcher profile on SciRah

Invite

J. Wampfler — researcher profile on SciRah

Invite

Zhi-Fu Sun — researcher profile on SciRah

S. Mandrekar×8

Invite

S. Mandrekar — researcher profile on SciRah

Invite

A. Jatoi — researcher profile on SciRah

Invite

Y. Garces — researcher profile on SciRah

Invite

J. Jett — researcher profile on SciRah

M. de Andrade×6

Invite

M. de Andrade — researcher profile on SciRah